CIK 0001826457 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Monte Rosa Therapeutics, Inc.
Sign in to watch- Ticker
- GLUE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-949-2643
- Business address
- 321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
- Former names
- Monte Rosa Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $137
- in 1 filing
Net −$137. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 35 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-28 | Versant Venture Capital VI, L.P. 10% owner | Other disposition | −20,397 | 0 | ||
| 2024-10-28 | Versant Venture Capital VI, L.P. 10% owner | Other acquisition | +17,595 | 17,595 | ||
| 2024-10-28 | Versant Venture Capital VI, L.P. 10% owner | Other disposition | −17,595 | 0 | ||
| 2024-10-28 | Versant Venture Capital VI, L.P. 10% owner | Other disposition | −366,590 | 1,641,358 | ||
| 2024-10-28 | Versant Venture Capital VI, L.P. 10% owner | Other acquisition | +5,499 | 5,499 | ||
| 2024-10-28 | Versant Venture Capital VI, L.P. 10% owner | Other disposition | −5,499 | 0 | ||
| 2024-10-28 | Versant Venture Capital VI, L.P. 10% owner | Other acquisition | +5,454 | 5,454 | ||
| 2024-10-28 | Versant Venture Capital VI, L.P. 10% owner | Other disposition | −5,454 | 0 | ||
| 2024-09-20 | Versant Venture Capital VI, L.P. 10% owner | Sale | −1,132,566 | $6.53 | $7.4M | 5,099,336 |
| 2024-09-13 | Versant Venture Capital VI, L.P. 10% owner | Sale | −9,269 | $6.16 | $57K | 6,231,902 |
| 2024-09-13 | Janku Filip Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-09-12 | Versant Venture Capital VI, L.P. 10% owner | Sale | −16,047 | $6.00 | $96K | 6,241,171 |
| 2024-09-11 | Versant Venture Capital VI, L.P. 10% owner | Sale | −541,897 | $6.00 | $3.3M | 6,257,218 |
| 2024-07-05 | Dunn Edmund Principal Accounting Officer | Sale | −1,610 | $3.83 | $6K | 13,944 |
| 2024-06-12 | Behbahani Ali Director | Grant or award · Stock Option (Right to Buy) | +22,100 | 22,100 | ||
| 2024-06-12 | Siu Christine Director | Grant or award · Stock Option (Right to Buy) | +22,100 | 22,100 | ||
| 2024-06-12 | SCHIFF ANDREW N Director | Grant or award · Stock Option (Right to Buy) | +22,100 | 22,100 | ||
| 2024-06-12 | Skvarka Jan Director | Grant or award · Stock Option (Right to Buy) | +22,100 | 22,100 | ||
| 2024-06-12 | Manning Anthony M. Director | Grant or award · Stock Option (Right to Buy) | +22,100 | 22,100 | ||
| 2024-06-12 | Blackwell Kimberly Director | Grant or award · Stock Option (Right to Buy) | +22,100 | 22,100 |
Page 7 of 9 · 174 trades